Key statistics
On Monday, Resmed Inc (RMD:ASX) closed at 39.35, -3.44% below its 52-week high of 40.75, set on Jan 30, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 39.01 |
---|---|
High | 39.37 |
Low | 38.88 |
Bid | -- |
Offer | -- |
Previous close | 38.95 |
Average volume | 851.76k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 0.3252 AUD |
---|---|
Annual div yield (ADY) | 0.83% |
Div ex-date | May 07 2025 |
Div pay-date | Jun 12 2025 |
Data delayed at least 20 minutes, as of Jun 30 2025 07:10 BST.
More ▼
- Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025
- Resmed Acquires VirtuOx
- Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025
- Resmed Names Salli Schwartz as Chief Investor Relations Officer
- Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US
- Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025
- New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer
- Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
- ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep
- ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025
More ▼